Skip to main content

3 Result(s)

within Emmanuel Mitry Remove this filter English Remove this filter Gastroenterology Remove this filter

and

  1. Article

    Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort

    Docetaxel–cisplatin-5-FU chemotherapy is superior to 5-FU-cisplatin in terms of response rate and survival in advanced gastric cancer (AGC), but is more toxic. Oxaliplatin is better tolerated than cisplatin, w...

    Simon Pernot, Emmanuel Mitry, Emmanuelle Samalin, Laetitia Dahan… in Gastric Cancer (2014)

    Download PDF (221 KB) View Article

  2. No Access

    Article

    Renal Cell Carcinoma with Gastric Metastases

    Hanane Inrhaoun, Ibrahim Elghissassi, Maya Gutierrez… in Journal of Gastrointestinal Cancer (2012)

  3. No Access

    Article

    Irinotecan as palliative chemotherapy for metastatic colorectal cancer: evolving tactics following initial treatment

    Patients with metastatic colorectal cancer (mCRC) who progress despite treatment with fluoropyrimidine and irinotecan or oxaliplatin have diminished survival, but they may derive clinically meaningful benefit ...

    Emmanuel Mitry, Astrid Lièvre… in International Journal of Colorectal Disease (2009)